Diagnosis and Treatment of STD Rashes
The appropriate diagnosis and treatment of STD rashes requires identification of the specific causative pathogen through clinical examination and laboratory testing, followed by pathogen-specific antimicrobial therapy according to CDC guidelines. 1
Diagnostic Approach
Clinical Presentation of Common STD Rashes
- Genital Herpes: Vesicular lesions that rupture to form painful ulcers
- Syphilis: Painless chancre (primary) or widespread maculopapular rash including palms/soles (secondary)
- Genital Warts: Flesh-colored papules with cauliflower-like appearance
- Scabies: Intense pruritus with burrows, papules, and vesicles
- Pubic Lice: Pruritus with visible lice or nits on pubic hair
Laboratory Testing
Visual inspection and microscopy:
- Dark-field microscopy for syphilis chancres
- Examine vesicle fluid for herpes using immunofluorescence staining 2
Specific testing based on presentation:
Treatment Algorithms by Specific STD Rash
1. Genital Herpes
First-line treatment:
- Episodic therapy: Famciclovir 1000 mg twice daily for 1 day at first sign of recurrence 4
- Suppressive therapy: Famciclovir 250 mg twice daily for chronic suppression 4
For HIV-infected patients:
- Famciclovir 500 mg twice daily for 7 days 4
Patient counseling:
- Not a cure; may have recurrences
- Avoid sexual contact when lesions present
- Asymptomatic viral shedding can still transmit infection 4
2. Syphilis
Primary, secondary, or early latent syphilis:
- Benzathine penicillin G 2.4 million units IM in a single dose 1
Late latent or unknown duration:
- Benzathine penicillin G 2.4 million units IM weekly for 3 weeks 1
Neurosyphilis:
- Aqueous crystalline penicillin G 18-24 million units IV daily for 10-14 days 1
- For penicillin-allergic patients, desensitization is required 3
3. Proctitis (rectal STD)
For patients with anorectal symptoms and recent receptive anal intercourse:
- Ceftriaxone 125 mg IM (single dose) PLUS
- Doxycycline 100 mg orally twice daily for 7 days 2
4. Ectoparasitic Infections
Pubic Lice (Pediculosis Pubis)
Recommended regimens:
- Permethrin 1% creme rinse applied to affected areas, washed off after 10 minutes, OR
- Pyrethrins with piperonyl butoxide applied to affected areas, washed off after 10 minutes 2, 1
For pregnant/lactating women:
- Permethrin or pyrethrins with piperonyl butoxide (avoid lindane) 2
Environmental measures:
- Decontaminate bedding and clothing (machine wash/dry using heat cycle) or remove from body contact for 72 hours 2
Scabies
Recommended regimens:
- Permethrin 5% cream applied to entire body from neck down, washed off after 8-14 hours, OR
- Lindane 1% lotion/cream applied thinly to all areas from neck down, washed off after 8 hours 2
Cautions with lindane:
- Do not use after bathing
- Avoid in pregnant/lactating women, children <2 years, or persons with extensive dermatitis 2
Partner Management
- Sex partners within the preceding month should be evaluated and treated for the same infection 2, 1
- Patients and partners should abstain from sexual activity until therapy is completed and both are asymptomatic 1
Follow-Up Recommendations
- Herpes: No routine follow-up if symptoms resolve
- Syphilis: Quantitative nontreponemal test titers at 6 months (should decline fourfold) 3
- Pubic lice/Scabies: Evaluate after 1 week if symptoms persist; retreat if necessary 2
- Proctitis: Follow-up based on specific etiology and symptom severity 2
Common Pitfalls to Avoid
- Failing to test for co-infections - Many STIs occur together; comprehensive testing is essential 1
- Inadequate partner treatment - Leads to reinfection cycles 1
- Relying solely on clinical appearance - Laboratory confirmation is necessary for accurate diagnosis 2
- Incomplete therapy - Ensure full course of treatment is completed 1
- Missing extragenital sites - Screen for rectal/pharyngeal infections in MSM and others with exposure risk 2
By following these evidence-based guidelines for diagnosis and treatment of STD rashes, clinicians can effectively manage these conditions and prevent complications including infertility, chronic pain, and increased HIV transmission risk.